ASCO

Adjuvant Ribociclib and Endocrine Therapy in Patients with HR+/HER2 Negative Early Breast Cancer: Phase III NATALEE Trial

By Dr. Shipra Gandhi from Roswell Park Comprehensive Cancer Center   Findings from the MonarchE clinical trial1 led to the…

11 months ago

IMBRAVE-151, A Phase II, Randomized, Double-Blind Placebo-Controlled Study of Atezolizumab with or without Bevacizumab in Combination with Cisplatin plus Gemcitabine in Patients with Untreated, Advanced Biliary Tract Cancer

Dr. Ghassan Abou-Alfa of Memorial Sloan Kettering Cancer Center shares a recent abstract from ASCO GI, IMBRAVE-151, A Phase II,…

1 year ago

Binaytara Foundation hosts ASCO Direct™ Highlights in Seattle

ASCO Direct™ Highlights Oncology conference held in Seattle to present and discuss the latest findings in cancer research and treatments…

2 years ago